Matches in Wikidata for { <http://www.wikidata.org/entity/Q107507841> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q107507841 description "clinical trial" @default.
- Q107507841 description "ensayo clínico" @default.
- Q107507841 description "ensayu clínicu" @default.
- Q107507841 description "klinisch onderzoek" @default.
- Q107507841 description "клінічне випробування" @default.
- Q107507841 description "临床试验" @default.
- Q107507841 name "Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma" @default.
- Q107507841 name "Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma" @default.
- Q107507841 type Item @default.
- Q107507841 label "Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma" @default.
- Q107507841 label "Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma" @default.
- Q107507841 prefLabel "Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma" @default.
- Q107507841 prefLabel "Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma" @default.
- Q107507841 P1050 Q107507841-2B0D8E09-D072-493C-9D41-6000A53D2C81 @default.
- Q107507841 P1132 Q107507841-30517504-6DBF-4047-B04D-1E02B479DFB5 @default.
- Q107507841 P1476 Q107507841-932151F1-0626-4F7E-91FC-E073E452970C @default.
- Q107507841 P17 Q107507841-6A68AF1B-F508-4F23-B34E-B26AD2740BCB @default.
- Q107507841 P2899 Q107507841-32B1B4FE-3CF6-4060-932B-CC8696F957D6 @default.
- Q107507841 P3098 Q107507841-40521945-BB0F-49FF-99D5-4291FF649A6B @default.
- Q107507841 P31 Q107507841-5BCC6D0F-767A-4A7B-96CE-31A58FF3EACB @default.
- Q107507841 P4844 Q107507841-0E6BADF0-AD20-4DF8-A995-349DBC337AEF @default.
- Q107507841 P4844 Q107507841-3904C614-EDD9-4DCE-B2AD-ECD2835168E0 @default.
- Q107507841 P4844 Q107507841-4C4E8E93-7DE4-41F4-8889-B6ED433A2221 @default.
- Q107507841 P4844 Q107507841-A297160C-4F0E-4B87-B692-ED972B53ACBC @default.
- Q107507841 P4844 Q107507841-C92734AC-6DF8-4124-8589-21925C41332B @default.
- Q107507841 P4844 Q107507841-FF60C48B-EABE-4E35-9F41-05A1539A5F6D @default.
- Q107507841 P580 Q107507841-60FE26A5-B2B5-4C8D-AAA7-844700E7A1F0 @default.
- Q107507841 P582 Q107507841-05644529-3BBA-4CF2-A8E6-DFBC8EBB26A7 @default.
- Q107507841 P6099 Q107507841-991BBCAC-24F7-4ECD-8916-330F87A6BAC9 @default.
- Q107507841 P767 Q107507841-66A5D5DA-A31E-42E8-8B28-AF8B9BD6B6E1 @default.
- Q107507841 P8005 Q107507841-928B9FE6-6514-4E70-88B2-B7678092DAD5 @default.
- Q107507841 P8363 Q107507841-AC24ED5B-01DB-4C8A-AE28-F6A2167951C5 @default.
- Q107507841 P1050 Q208414 @default.
- Q107507841 P1132 "+33" @default.
- Q107507841 P1476 "A Phase 2 Trial of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy (aTac-BEAM) Conditioning for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma" @default.
- Q107507841 P17 Q30 @default.
- Q107507841 P2899 "+18" @default.
- Q107507841 P3098 "NCT04871607" @default.
- Q107507841 P31 Q30612 @default.
- Q107507841 P4844 Q180983 @default.
- Q107507841 P4844 Q27260984 @default.
- Q107507841 P4844 Q415869 @default.
- Q107507841 P4844 Q418702 @default.
- Q107507841 P4844 Q418817 @default.
- Q107507841 P4844 Q421193 @default.
- Q107507841 P580 "2021-08-02T00:00:00Z" @default.
- Q107507841 P582 "2023-11-13T00:00:00Z" @default.
- Q107507841 P6099 Q42824440 @default.
- Q107507841 P767 Q664846 @default.
- Q107507841 P8005 Q76649708 @default.
- Q107507841 P8363 Q78089383 @default.